67 related articles for article (PubMed ID: 26369711)
21. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
[TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of roxithromycin against Chlamydia trachomatis.
Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
[TBL] [Abstract][Full Text] [Related]
23. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin.
Wyrick PB; Knight ST
J Antimicrob Chemother; 2004 Jul; 54(1):79-85. PubMed ID: 15163653
[TBL] [Abstract][Full Text] [Related]
24. Progesterone antagonizes the positive influence of estrogen on Chlamydia trachomatis serovar E in an Ishikawa/SHT-290 co-culture model.
Kintner J; Schoborg RV; Wyrick PB; Hall JV
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25724891
[TBL] [Abstract][Full Text] [Related]
25. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA
Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227
[TBL] [Abstract][Full Text] [Related]
27. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
28. Genital Chlamydia infections.
Ehret JM; Judson FN
Clin Lab Med; 1989 Sep; 9(3):481-500. PubMed ID: 2676319
[TBL] [Abstract][Full Text] [Related]
29. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
Bébéar CM; de Barbeyrac B; Pereyre S; Renaudin H; Clerc M; Bébéar C
Clin Microbiol Infect; 2008 Aug; 14(8):801-5. PubMed ID: 18727805
[TBL] [Abstract][Full Text] [Related]
30. Minocycline in the treatment of nongonococcal urethritis: its effect on Chlamydia trachomatis.
Oriel JD; Reeve P; Nicol CS
J Am Vener Dis Assoc; 1975 Sep; 2(1):17-22. PubMed ID: 1158770
[TBL] [Abstract][Full Text] [Related]
31. The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 degrees C.
Huston WM; Swedberg JE; Harris JM; Walsh TP; Mathews SA; Timms P
FEBS Lett; 2007 Jul; 581(18):3382-6. PubMed ID: 17604025
[TBL] [Abstract][Full Text] [Related]
32. [Immunotypes of Chlamydia trachomatis and the clinical picture of non-gonorrheal urethritis in men and cervicitis in women].
Selibórska Z; Mroczkowski TF; Martin D; Moore L
Przegl Dermatol; 1990; 77(4):272-5. PubMed ID: 2267357
[TBL] [Abstract][Full Text] [Related]
33. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
Bhengraj AR; Srivastava P; Mittal A
Int J Antimicrob Agents; 2011 Aug; 38(2):178-9. PubMed ID: 21570258
[No Abstract] [Full Text] [Related]
34. Tetracycline-resistant Chlamydia trachomatis in Toulouse, France.
Lefevre JC; Lepargneur JP; Guion D; Bei S
Pathol Biol (Paris); 1997 May; 45(5):376-8. PubMed ID: 9296087
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
Catalan F; Milovanovic A; Prouteau C; Soulignac M
Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
[TBL] [Abstract][Full Text] [Related]
36. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.
Renault CA; Israelski DM; Levy V; Fujikawa BK; Kellogg TA; Klausner JD
Sex Health; 2011 Mar; 8(1):69-73. PubMed ID: 21371385
[TBL] [Abstract][Full Text] [Related]
37. Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D.
Rupp J; Solbach W; Gieffers J
J Antimicrob Chemother; 2008 Jan; 61(1):91-4. PubMed ID: 18033786
[TBL] [Abstract][Full Text] [Related]
38. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
Bai H; Dong J; Ning B
Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
[TBL] [Abstract][Full Text] [Related]
39. Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis.
Sweet RL; Schachter J; Robbie MO
JAMA; 1983 Nov; 250(19):2641-5. PubMed ID: 6632163
[TBL] [Abstract][Full Text] [Related]
40. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
